ArticleCancers2026

Oncologic and Surgical Outcomes After Short-Course Neoadjuvant CAPOX Plus Bevacizumab in High-Risk Colorectal Liver Metastases.

Yawen Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.